GemPharmatech is a leading provider of genetically engineered mouse models (GEMMs) and preclinical services for research and drug development. With a collection of over 20,000 GEMMs, they specialize in developing animal models using cutting-edge gene-editing technologies, including knockout and conditional knockout mouse models, disease mouse models, immunodeficient mouse models, and germ-free mouse models.
Driven by a commitment to accelerating innovation, GemPharmatech offers a range of services, including custom model generation, preclinical testing, cell lines and customization, custom breeding, and germ-free and microbiome services. Their state-of-the-art facilities and expertise in CRISPR Cas9 gene-editing technology make them a trusted partner for global preclinical R&D communities.
Generated from the website
